CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$79.22
−3.31%Margins
Gross margin
98.5%
EBITDA margin
13.3%
EBIT margin
11.5%
Net margin
16.6%
FCF margin
20.2%
19.2%
Return on equity
15.4%
Return on assets
13.2%
Return on invested capital
1.00x
Asset turnover
$198.1M
Cash from operations
$3.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026